Showing results (51-60 of 903) with videos related to

Sort By:
Pageof 91
Annals of Internal Medicine|October 1, 1984
Efficacy of intravenous immunoglobulin in primary humoral immunodeficiency diseaseC Cunningham-Rundles, F P Siegal, E M Smithwick, et al.
Scandinavian Journal of Immunology|March 1, 1982
Impaired proliferative response to B-lymphocyte activators in common variable immunodeficiencyS Cunningham-Rundles, C Cunningham-Rundles, D I Ma, et al.
The Journal of Clinical Investigation|May 1, 1985
Cross-reactive idiotypes in immunoglobulin A-deficient seraM K Cheung, C Cunningham-Rundles, J Koistinen
Annals of Internal Medicine|October 27, 1997
Granulomatous disease in common variable immunodeficiencyL J Mechanic, S Dikman, C Cunningham-Rundles
Vox Sanguinis|January 1, 1986
Intravenous treatment of autoimmune hemolytic anemia with very high dose gammaglobulinJ B Bussel, C Cunningham-Rundles, C Abraham
Cancer Investigation|January 1, 1997
Vinorelbine (Navelbine): a third-generation vinca alkaloidD R Budman
Investigational New Drugs|November 18, 2000
CapecitabineD R Budman
Clinical Immunology (Orlando, Fla.)|December 9, 2000
Characterization of the T cell receptor repertoire in patients with common variable immunodeficiency: oligoclonal expansion of CD8(+) T cellsD Serrano, K Becker, C Cunningham-Rundles, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|March 1, 1995
Immunologic effects of low-dose polyethylene glycol-conjugated recombinant human interleukin-2 in common variable immunodeficiencyC Cunningham-Rundles, K Kazbay, Z Zhou, et al.
Journal of Immunological Methods|August 10, 1992
Biological activities of polyethylene-glycol immunoglobulin conjugates. Resistance to enzymatic degradationC Cunningham-Rundles, Z Zhuo, B Griffith, et al.
Pageof 91